Collegium Pharmaceutical Inc (COLL)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 1,143,310 1,177,580 1,213,910 1,214,300 1,174,130 1,200,940 1,245,570 1,246,140 692,077 741,803 713,735 646,065 643,841 643,843 646,870 634,793 306,302 303,978 301,581 294,362
Total stockholders’ equity US$ in thousands 195,431 178,873 200,805 179,733 194,842 197,194 197,612 196,076 202,928 251,094 253,066 170,035 186,031 172,686 155,767 141,063 87,432 84,258 85,823 86,350
Financial leverage ratio 5.85 6.58 6.05 6.76 6.03 6.09 6.30 6.36 3.41 2.95 2.82 3.80 3.46 3.73 4.15 4.50 3.50 3.61 3.51 3.41

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,143,310K ÷ $195,431K
= 5.85

The financial leverage ratio of Collegium Pharmaceutical Inc has demonstrated fluctuations over the quarters in the period indicated. The ratio, which measures the company's level of debt in relation to equity, varied between Q1 2022 and Q4 2023, ranging from 5.85 to 6.76.

The trend indicates that the company's reliance on debt has been relatively high, with the ratio consistently above 5. This suggests that Collegium Pharmaceutical Inc has been leveraging its capital structure with a significant amount of debt compared to equity over the period analyzed.

It is important to note that a higher financial leverage ratio signifies a higher level of financial risk due to increased debt obligations, which can potentially impact the company's financial stability and ability to meet its financial obligations.

Further analysis and monitoring of the financial leverage ratio trend will be necessary to assess the company's ability to manage its debt effectively and maintain a sustainable capital structure.